National service frameworks (NSFs) were ten-year programmes for improving specific areas of health and social care. They set measurable goals within set time frames. They were only applicable to the NHS in England.

Multiple sclerosis (MS) was first recognised as a condition in the middle of the 19th century. Prior to this time, there are reports of a few instances of what may have been MS, although the variety of symptoms, the range of other possible causes and the incompleteness of records make these impossible to confirm.

UTIs are common if you have MS but can throw up a few curveball symptoms. This is what you (and those closest to you) need to keep an eye on.

Planning for the end of life is something we can all be thinking about, no matter our age or our health. Here are some suggestions to help you begin the conversation around end of life planning with your loved ones.

Aromatherapy is a complementary therapy used by some people with multiple sclerosis (MS), where essential oils are used to promote wellbeing and relaxation.

Low vitamin D levels have been linked with an increased risk of getting MS, but also with more frequent relapses and increased disability in those with established multiple sclerosis.

Laquinimod was developed as a treatment for multiple sclerosis. Following disappointing clinical trial results, the manufacturer discontinued development of it in MS.

Riluzole is a glutamate receptor blocker used in the treatment of ALS, a form of motor neurone disease.

Donepezil (Aricept) is a drug used in the treatment of Alzheimer's disease which has been studied as a treatment for impaired memory in people with multiple sclerosis (MS).